Revent
VC Fund
Berlin, Germany
Revent is a VC fund in Berlin focused on Software and Information Technology. Today’s immense climate and societal challenges will not be solved without visionary entrepreneurs creating tomorrow’s most innovative companies.We gather a community of purpose-led founders, investors and scientists to drive systemic change in climate, healthcare, education and finance. Our role is to provide founders the platform tosucceed, supporting them with capital, relevant networks and an aligned mission.We believe that in today’s world, the companies founded by extraordinary teams around a strong purpose, will be the ones to succeed and thrive.
- Total investments:
- 44
- Last investment:
- Lead investor:
- 34%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Revent invests in
Stages Revent invests in
Countries Revent invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.9M–$10M
- Pre-Seed
- $1M–$3.5M
- Series A
- $11M–$31M
Investment Focus
Industry
- Software 8 (18%)
- Information Technology 6 (14%)
- Artificial Intelligence 6 (14%)
- Sustainability 5 (11%)
- Health Care 4 (9%)
Stage
- Seed 20 (45%)
- Pre-Seed 13 (30%)
- Series A 6 (14%)
- Series B 2 (5%)
- Funding Round 1 (2%)
Country
- Germany 10 (23%)
- United Kingdom 6 (14%)
- France 4 (9%)
- Denmark 2 (5%)
- Switzerland 2 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Benjamin Otto
Founder
|
Founder | Total investments: 2 | Find email | |
Henrik Grosse Hokamp
Partner
|
Partner | Total investments: 8 | Find email | |
Jan Weiss
Advisor & LP
|
Advisor & LP | Total investments: 0 | Find email | |
Lauren Lentz
General Partner; General Partner
|
General Partner; General Partner | Total investments: 5 | Find email | |
Marie Fabiunke
Advisor
|
Advisor | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Oska Health
|
Oska Health delivers digital-enabled care solutions for chronic kidney disease patients, a top clinical need for healthcare payers. By leveraging evidence-based medical best practices and behavioral science, Oska Health aims to empower individuals with kidney disease to mitigate their risk of cardiovascular complications and kidney failure whilesimultaneously lowering costs of care. The company partners with healthcare payers to provide a comprehensive solution that includes a personal coach, a state-of-the-art health app, and intelligent treatment plan algorithms, all designed to help individuals establish new routines and achieve optimal health outcomes. | $13M / Seed / Feb 26, 2026 | |
Newable
|
Newable provides solar energy solutions for generating, storing, and managing renewable power for commercial and industrial users. The company develops and finances solar installations, including rooftop and ground-mounted systems, along with battery storage integration to support energy usage and resilience. Its services include projectdevelopment, system design, installation coordination, and ongoing asset management. | $4.7M / Pre-Seed / Jan 30, 2026 | |
Tem-Energy
|
Until now, businesses have had to buy power via Big Energy putting up with overpricing, sapping levels of service and glacial innovation. Now with tem. any company can buy Renewable Energy Direct. This allows businesses to save on energy costs whilst renewable generators are rewarded. | $75M / Series B / Jan 26, 2026 | |
One.Five
|
A biotech platform to scale applied material science. | $16.3M / Series A / Jan 19, 2026 | |
Mirantus Health
|
Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients. | $6.3M / Seed / Nov 20, 2025 | |
Revolt.eco
|
Revolt.eco is the leading OS powered by automation and AI, enabling renewable energy installers to work faster, smarter, and grow their business. | $2.5M / Pre-Seed / Nov 17, 2025 | |
NetZeroNitrogen
|
We are developing a highly disruptive alternative product for the $200 billion synthetic fertilizer market, thereby helping farmers worldwide to achieve same or better yields for less cost, less effort and less damage to the farm and its environment. | $6.7M / Seed / Jul 23, 2025 | |
ScienceMachine
|
ScienceMachine is an AI startup accelerating biotech data analysis with a fully autonomous agent, | $3.5M / Pre-Seed / Jul 09, 2025 | |
Perry
|
Perry uses AI technology to create and deliver clear, step-by-step work and safety instructions. Their platform is designed to help organizations quickly generate instructional content, such as onboarding materials or safety protocols, in minutes rather than weeks. This service is particularly useful for onboarding new team members or ensuringconsistent training and safety compliance across teams. | $1.9M / Seed / Jul 07, 2025 | |
Wallround
|
Wallround is a startup that creates AI-powered technology that "allows for an accurate cost forecast and profitability calculation for planned renovations with just a few mouse clicks." | $4.9M / Seed / Jun 24, 2025 | |
| See all 44 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Revent invest in?
Revent invests primarily in Software, Information Technology and Artificial Intelligence startups, most often at Seed and Pre-Seed stage. Most of the 44 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Revent's check size?
Revent typically joins rounds of $1.9M–$10M at Seed, $1M–$3.5M at Pre-Seed and $11M–$31M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Revent participates in.
How do I contact Revent?
Public channels for Revent include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Revent?
The team at Revent includes Benjamin Otto (Founder), Henrik Grosse Hokamp (Partner) and Jan Weiss (Advisor & LP), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
